Clinical Trials Logo

Gastric Cancer Stage clinical trials

View clinical trials related to Gastric Cancer Stage.

Filter by:
  • None
  • Page 1

NCT ID: NCT06342427 Recruiting - Gastric Cancer Clinical Trials

Stomach Cancer Exosome-based Detection

DESTINEX
Start date: March 15, 2023
Phase:
Study type: Observational

Gastric cancer continues to have a poor prognosis primarily due to the inability to detect it in its early stages. This study will develop and validate a blood assay to facilitate the non-invasive detection of gastric cancer.

NCT ID: NCT06281379 Completed - Gastric Cancer Clinical Trials

Complete Mesogastric Excision With D2 Lympadenectomy for Gastric Cancer:

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

Objective: To define complete mesogastric excision and compare our short term results for the first time in a different population. Study design:Randomised-controlled study Place and duration of the study: Gastroenterological Surgery Clinic,Health Sciences University,Basaksehir City Hospital,Istanbul,Turkey,from April to December 2023. Methodology: We compared short term results of open total gastrectomy+ mesogastrectomy with standard total gastrectomy + D2 lymph node dissection at a tertiary center in terms of peroperative results, histopathological findings and postoperative short- term outcomes with review of the literature. Conclusion: Our aim is to show that mesogastric excision is safe and has advantages over conventional D2 gastrectomy in means of not only peroperative and short-term outcomes, but also disease free survival.Our work is the first study from a different population of the world and our initial results can contribute to the literature for universalization.

NCT ID: NCT05592925 Recruiting - Clinical trials for Lymph Node Metastasis

Association Between Multiple Coagulation-related Factors and Lymph Node Metastasis in Patients With Gastric Cancer: A Retrospective Cohort Study

MA
Start date: January 1, 2018
Phase:
Study type: Observational

We initially selected a total of 1128 patients with primary gastric cancer who presented at Shandong Provincial Hospital between January 2018 and October 2022, and retrospectively collected their clinical and pathological data. And retrospectively analyzed preoperative baseline characteristics, preoperative laboratory tests, and postoperative pathological results for these patients

NCT ID: NCT05508126 Recruiting - Clinical trials for Gastric Cancer Stage

Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer

Start date: November 1, 2021
Phase:
Study type: Observational

Accurate preoperative staging of gastric cancer is of major importance for guiding therapeutic decision-making, preventing both under- and over-treatment. The purpose of this study is to investigate the diagnostic performance of the Multi-parametric magnetic resonance imaging (mpMRI) and dual-energy computed tomography (DECT) in gastric cancer.

NCT ID: NCT04440605 Recruiting - Gastric Cancer Clinical Trials

A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis

Start date: July 1, 2020
Phase:
Study type: Observational
Read more »
NCT ID: NCT04028375 Recruiting - Neoadjuvant Therapy Clinical Trials

Study of CT and MR in the Gastric Cancer

Start date: September 1, 2019
Phase:
Study type: Observational
Read more »
NCT ID: NCT03015298 Not yet recruiting - Clinical trials for Gastric Cancer Stage

Comparing the Diagnostic Role of PET/MRI and of PET/CT Among Patients With Gastric Cancer

Start date: January 2017
Phase: N/A
Study type: Observational

The results of PET/MRI and PET/CT in each recruited gastric cancer patients will be compared.